Erasca Reports Third Quarter 2024 Business Updates and Financial Results
Provided By GlobeNewswire
Last update: Nov 12, 2024
Positive preliminary Phase 1b data in SEACRAFT-1 NRASm melanoma cohort bolsters conviction in ongoing SEACRAFT-2 registrational trial; Stage 1 randomized data expected in 2025
Read more at globenewswire.com
